These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15761410)

  • 1. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists.
    Colodner R
    Am J Infect Control; 2005 Mar; 33(2):104-7. PubMed ID: 15761410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-spectrum beta-lactamase-producing organisms.
    Falagas ME; Karageorgopoulos DE
    J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.
    Yu WL; Chuang YC; Walther-Rasmussen J
    J Microbiol Immunol Infect; 2006 Aug; 39(4):264-77. PubMed ID: 16926972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit].
    Mhand RA; Soukri A; Amarouch H; Mdaghri NE; Benbachir M
    Sante; 1999; 9(6):341-4. PubMed ID: 10705312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-spectrum beta-lactamases.
    Turner PJ
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S273-5. PubMed ID: 16032564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
    Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
    Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of an infection control programme to limit the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Belgian university hospital.
    Christiaens G; Barbier C; Warnotte J; Mutsers J
    J Hosp Infect; 2008 Apr; 68(4):366-7. PubMed ID: 18329138
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
    Cantón R; Novais A; Valverde A; Machado E; Peixe L; Baquero F; Coque TM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():144-53. PubMed ID: 18154538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment.
    Rupp ME; Fey PD
    Drugs; 2003; 63(4):353-65. PubMed ID: 12558458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum beta-lactamases. An overview.
    Patterson JE
    Postgrad Med; 2001 Feb; 109(2 Suppl):32-8. PubMed ID: 19667555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.
    Pitout JD; Nordmann P; Laupland KB; Poirel L
    J Antimicrob Chemother; 2005 Jul; 56(1):52-9. PubMed ID: 15917288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extended-spectrum beta-lactamase producing-enterobacteriaceae].
    Mariani-Kurkdjian P; Doit C; Bingen E
    Arch Pediatr; 2012 Nov; 19 Suppl 3():S93-6. PubMed ID: 23178141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.
    Pfaller MA; Segreti J
    Clin Infect Dis; 2006 Apr; 42 Suppl 4():S153-63. PubMed ID: 16544266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-spectrum beta-lactamases in North America, 1987-2006.
    Bush K
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():134-43. PubMed ID: 18154537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended spectrum beta lactamase--mediated resistance among isolates of family Enterobacteriaceae.
    Deep ; Arora U
    Indian J Pathol Microbiol; 2007 Apr; 50(2):458-61. PubMed ID: 17883109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases.
    Endimiani A; Paterson DL
    Semin Respir Crit Care Med; 2007 Dec; 28(6):646-55. PubMed ID: 18095228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
    Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
    J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition and management of extended spectrum beta lactamase producing organisms (ESBL).
    Fircanis S; McKay M
    Med Health R I; 2010 May; 93(5):161-2. PubMed ID: 20533728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
    Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
    J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.